Results 211 to 220 of about 72,205 (239)

[Transrectal ozone and magnetic therapy for treatment of chronic bacterial prostatitis].

Urologiia, 2020
AIM To evaluate the efficiency of combined transrectal ozone and magnetic therapy for the treatment of chronic bacterial prostatitis (CBP). MATERIALS AND METHODS A total of 142 men with CBP were included in the study and allocated to different ...
M. I. Katibov, M. M. Alibekov
semanticscholar   +1 more source

[Characterization of the microbiota and cytokine profile of sperm plasma in men with chronic bacterial prostatitis].

Urologiia, 2020
BACKGROUND One of the leading causes of the occurrence of chronic bacterial prostatitis (CBP) in men is infection, microecological disorders of the urogenital tract and cytokine-mediated mechanisms of inflammation of the prostate gland, which actualizes ...
O. Bukharin, M. D. Kuzmin, N. Perunova, E. Ivanova, A. V. Bekpergenova, T. A. Bondarenko   +5 more
semanticscholar   +1 more source

The Use of a Combination of Vaccinium Macracarpon, Lycium barbarum L. and Probiotics (Bifiprost®) for the Prevention of Chronic Bacterial Prostatitis: A Double-Blind Randomized Study

Urologia internationalis, 2019
Introduction: To evaluate the efficacy of Bifiprost® + Serenoa Repens 320 mg versus Serenoa Repens 320 mg alone for the prevention of chronic bacterial prostatitis (CBP) due to enterobacteriaceae.
F. Chiancone, M. Carrino, C. Meccariello, L. Pucci, M. Fedelini, P. Fedelini   +5 more
semanticscholar   +1 more source

Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study

Chemotherapy, 2019
Background: Mounting worldwide resistance trends make the use of fluoroquinolone (FQ) antibacterial agents increasingly difficult. This is felt more acutely in the case of urogenital infections, which are mainly caused by Gram-negative pathogens.
V. Magri, G. Perletti, T. Cai, K. Stamatiou, A. Trinchieri, E. Montanari   +5 more
semanticscholar   +1 more source

Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.

Acta Biomaterialia, 2022
Jun Zheng, Ruimin Hu, Yang Yang, Yu Wang, Qianmei Wang, Senlin Xu, Pu Yao, Zhiyong Liu, Jiangling Zhou, Jing Yang, Ying Bao, Dinglin Zhang, Wenhao Shen, Zhansong Zhou   +13 more
semanticscholar   +1 more source

Onconephrology: The intersections between the kidney and cancer

Ca-A Cancer Journal for Clinicians, 2021
, Kenar D Jhaveri, Mark A Perazella
exaly  

Intermittent fasting in the prevention and treatment of cancer

Ca-A Cancer Journal for Clinicians, 2021
Katherine Clifton, Luigi Fontana, Lindsay L Peterson, Mscr   +2 more
exaly  

Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis.

International Journal of Antimicrobial Agents
N. Cesta, Alessandro Fusco, C. Ferretti, Alessandro Materazzi, Anna Altieri, C. D’Agostini, Marco Iannetta, M. Andreoni, A. Tavanti, L. Sarmati, Mariagrazia Di Luca   +10 more
semanticscholar   +1 more source

Management of Chronic Bacterial Prostatitis

Current Urology Reports, 2020
Z. Su, J. Zenilman, K. Sfanos, A. Herati
semanticscholar   +1 more source

Cancer care for people with dementia: Literature overview and recommendations for practice and research

Ca-A Cancer Journal for Clinicians, 2023
Laura Ashley
exaly